---
figid: PMC3813893__fmicb-04-00321-g0001
figtitle: Action of cationic antitumor peptides
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3813893
filename: fmicb-04-00321-g0001.jpg
figlink: /pmc/articles/PMC3813893/figure/F1/
number: F1
caption: Mechanisms of action of cationic antitumor peptides. (1) Modification of
  the lysosome membrane leading to an acidification of the intracellular environment
  and cell death. (2) Amplification of the proteasome activity. (3) Induction of mitochondrial
  pathway of apoptosis by either the cytochrome c release into the cytoplasm or activation
  of the caspase cascade. (4) Pore formation by the carpet model. (5) Increase of
  the influx of Ca2+. (6) Formation of pore by either the toroidal or the barrel-stave
  models. (7) Activation of an immune modulatory pathway by induction of NK and IFN.
  (8) Inhibition of genes involved in DNA replication. (9) Arrest of cell cycle G0,
  G1, or S phases. Lfcin, lactoferrcin; BMAP, bovine myeloid antimicrobial peptide;
  Cr-AMP, Chlorella pyrenoidosa antitumor polypeptide.
papertitle: 'Current scenario of peptide-based drugs: the key roles of cationic antitumor
  and antiviral peptides.'
reftext: Kelly C. L. Mulder, et al. Front Microbiol. 2013;4:321.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9495558
figid_alias: PMC3813893__F1
figtype: Figure
redirect_from: /figures/PMC3813893__F1
ndex: 56b3beaa-def7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3813893__fmicb-04-00321-g0001.html
  '@type': Dataset
  description: Mechanisms of action of cationic antitumor peptides. (1) Modification
    of the lysosome membrane leading to an acidification of the intracellular environment
    and cell death. (2) Amplification of the proteasome activity. (3) Induction of
    mitochondrial pathway of apoptosis by either the cytochrome c release into the
    cytoplasm or activation of the caspase cascade. (4) Pore formation by the carpet
    model. (5) Increase of the influx of Ca2+. (6) Formation of pore by either the
    toroidal or the barrel-stave models. (7) Activation of an immune modulatory pathway
    by induction of NK and IFN. (8) Inhibition of genes involved in DNA replication.
    (9) Arrest of cell cycle G0, G1, or S phases. Lfcin, lactoferrcin; BMAP, bovine
    myeloid antimicrobial peptide; Cr-AMP, Chlorella pyrenoidosa antitumor polypeptide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAMP
  - ADSL
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - GJA8
  - IFNA1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CENPJ
  - Alloferon
  - Paradoxin
  - Melittin
---
